7:59:57AM Page 1 of 1
|
|
- Reynard Preston
- 5 years ago
- Views:
Transcription
1 Daily Log AP Diagnostics 935 Sundrop t MRN Patient Name DOB Sex Accession ollected Ordered Physician Procedure Status Location Pastuer,Louis 05/25/1947 M AP-Visions linic BASI METABOLI PROFILE OMPLETE BLOOD OUNT V UA DIPSTIK ONLY V Nightingale,Florance 07/21/1998 F /14/ :35:00 AM 09/14/ :35:00 AM AP-Visions linic BASI METABOLI PROFILE OMPLETE BLOOD OUNT UA DIPSTIK ONLY Jenner,Edward 09/21/1968 M /14/ :49:00 AM 09/14/ :49:00 AM AP-Visions linic DRUG SREEN 9/14/2016 7:59:57AM Page 1 of 1
2 omplete Work Report AP Diagnostics 935 Sundrop t Accession Patient Name MRN Status Procedure ontainer Status Louis Pastuer S BASI METABOLI PROFILE Serum Red Top OMPLETE BLOOD OUNT Lavender Top e/edta Urine ontrainer UA DIPSTIK ONLY Urine ontrainer Florance Nightingale BASI METABOLI PROFILE Serum Red Top OMPLETE BLOOD OUNT Lavender Top e/edta UA DIPSTIK ONLY Urine ontrainer Edward Jenner DRUG SREEN Urine ontrainer Urine ontrainer S V V 9/14/2016 8:04:05AM Page 1 of 1
3 Abnormal Report by Doctor Nightingale,Florance MRN: Accession: HT % 58.0 h 38.5 to HGB g/dl 12.0 l 13.2 to 17.1 RB x10^6/ul 5.85 h 4.20 to 5.80 WB x10^3/ul 12.1 h 3.8 to 10.8 Pastuer,Louis MRN: Accession: BILIRUBIN 3+ h HGB g/dl 17.2 h 13.2 to 17.1 KETONE TRAE h LEUKOYTES SMALL h URINE REATININE 11 l 20 to 350 WB x10^3/ul 3.7 l 3.8 to 10.8 AP Diagnostics 935 Sundrop t 9/14/2016 9:02:15AM Page 1 of 1
4 Test Tally By Ordered DateTime From 08/01/ :00 To 08/31/ :41 For Test Tally 935 Sundrop t Test ode Test Name ount 6MAM 6-MAM 1 AMPHET AMPHETAMINES 2 DRUG FTRA DRUG ONFIRMATION 8 DRUGS DRUG SREEN 8 3 SPG Specific Gravity 3 URE URINE REATININE 3 Totals Page 1 of 1 9/14/2016 7:15:49AM
5 AP Diagnostics 935 Sundrop t Inquiry Lab Director: Dr. Robert Weachter Phone: Fax: Patient: Louis Pastuer DOB: 05/25/1947 SEX: M MRN: Accession: Non-Fasting Requesting Physician: Requesting Location: AP-Visions linic Order DT ollected DT Received DT Reported DT 09/14/ :16:33 PM Test Normal Abnormal Flag Units Reference Range Tech BASI METABOLI PROFILE BUN/REAT RATIO 0.9 l AL 6.0 to 22.0 Adm BUN 13 mg/dl 7 to 20 Adm ALIUM 8.6 mg/dl 8.5 to 10.5 Adm HLORIDE 112 h mmol/l 94 to 110 Adm ARBON DIOXIDE 20 l meq/l 21 to 32 Adm REATININE ug/dl < Adm GLUOSE 700 H mg/dl 50 to Adm POTASSIUM 3.6 mmol/l 3.5 to 5.5 Adm SODIUM 141 mmol/l 135 to 148 Adm OMPLETE BLOOD OUNT HT 41.6 % 38.5 to Adm HGB 17.2 h g/dl 13.2 to 17.1 Adm LYMPH# 1.1 # 0.6 to 4.1 Adm LYMPH% 22.0 % 10.0 to 58.5 Adm MH 31.0 pg 27.0 to 33.0 Adm MH 34.5 g/dl 32.0 to 36.0 Adm MV 91.6 fl 80.0 to Adm PLT 205 x10^3/ul 140 to 400 Adm RB 4.25 x10^6/ul 4.20 to 5.80 Adm WB 3.7 l x10^3/ul 3.8 to 10.8 Adm MID% 22.0 % 0.1 to 24.0 Adm MID# to 1.8 Adm GRA% 46.3 % 37.0 to 92.0 Adm GRA# to 7.8 Adm RDW 12.0 % 11.0 to 15.0 Adm MPV 29 fl 0 to 50 Adm DRUG SREEN 7.0 Adm URINE REATININE 11 l 20 to 350 Adm to Adm Specific Gravity g/ml to Adm UA DIPSTIK ONLY APPEARANE LEAR Adm BILIRUBIN 3+ h Adm BLOOD NEGATIVE Adm OLOR AMBER Adm GLUOSE NEGATIVE Adm KETONE TRAE h Adm LEUKOYTES SMALL h Adm NITRITE NEGATIVE Adm 7.0 Adm PROTEIN NEGATIVE Adm SPEIFI GRAVITY Adm UROBILINOGEN Normal Adm Specific Gravity to Adm Specific Gravity to Adm URINE REATININE 11 l 20 to 350 Adm 7.0 Adm
6 AP Diagnostics 935 Sundrop t Inquiry Lab Director: Dr. Robert Weachter Phone: Fax: Patient: Louis Pastuer DOB: 05/25/1947 SEX: M MRN: Accession: Non-Fasting Requesting Physician: Requesting Location: AP-Visions linic Order DT ollected DT Received DT Reported DT 09/14/ :16:33 PM Test Result oncentration utoff Units Tech DRUG SREEN AMPHETAMINES Positive Adm BARBITUATES 2 Adm BENZODIAZEPINES 2 Adm BUPRENORPHRINE 2 20 Adm ANNABINOIDS Positive Adm OAINE 0 Adm METHADONE 0 Adm METHAMPHETAMINES Adm OPIATES 0 Adm OXYODONE 0 Adm PHENYLIDINE 0 25 Adm TRAMADOL 0 Adm FENTANYL 0 2 Adm ETHANOL Adm TRIYLI ANTIDEPRESSANT (TA) Positive 500 Adm Note: These tests were developed and their performance characteristics determined by AP Diagnostics and have not been cleared or approved by the FDA. The laboratory is regulated under LIA as qualified to perform high-complexity testing. These tests are used for clinical purposes only and should not be used for workplace drug testing, athletic doping control, or in any other forensic or legal context where chain of custody is required.
7 935 Sundrop t AP Diagnostics Lab Director: Dr. Robert Weachter Phone: Fax: Patient: Louis Pastuer MRN#: DOB: 05/25/1947 Sex: M Attending Physician: Inquiry Patient Location: AP-Visions linic Reported Date: 09/17/ :15:52 AM Accession ollected Date ollected Time BASI METABOLI PROFILE BUN/REAT RATIO BUN ALIUM HLORIDE ARBON DIOXIDE REATININE GLUOSE POTASSIUM SODIUM OMPLETE BLOOD OUNT HT HGB LYMPH# LYMPH% MH MH MV PLT RB WB MID% MID# GRA% GRA# RDW MPV DRUG SREEN URINE REATININE AMPHETAMINES BARBITUATES BENZODIAZEPINES BUPRENORPHRINE ANNABINOIDS OAINE METHADONE METHAMPHETAMINES OPIATES OXYODONE PHENYLIDINE Specific Gravity TRAMADOL FENTANYL ETHANOL TRIYLI ANTIDEPRESSANT (TA) /16/ :13:00 AM /14/ :31:00 AM 1.0 l 0.9 l h l h 700 H h l h l 11 l Positive Positive Positive Page 1 of 2
8 935 Sundrop t AP Diagnostics Lab Director: Dr. Robert Weachter Phone: Fax: Patient: Louis Pastuer MRN#: DOB: 05/25/1947 Sex: M Attending Physician: Inquiry Patient Location: AP-Visions linic Reported Date: 09/17/ :15:52 AM Accession ollected Date ollected Time UA DIPSTIK ONLY APPEARANE BILIRUBIN BLOOD OLOR GLUOSE KETONE LEUKOYTES NITRITE PROTEIN SPEIFI GRAVITY UROBILINOGEN Specific Gravity Specific Gravity URINE REATININE /16/ :13:00 AM /14/ :31:00 AM LEAR LEAR 1+ h 3+ h NEGATIVE NEGATIVE AMBER AMBER NEGATIVE NEGATIVE NEGATIVE TRAE h TRAE h SMALL h NEGATIVE NEGATIVE NEGATIVE NEGATIVE Normal Normal l 11 l Page 2 of 2
9 AP Diagnostics 935 Sundrop t Laboratory Report Phone: Fax: PATIENT INFORMATION Patient Name: MRN: Alexander Fleming Patient DOB: 05/19/1993 Sample ID: Ordering Physician: REQUESTER INFORMATION Practice Name: Practice Address: AP Visions LL 395 Sundrop t REPORTED LINIAL HISTORY - PRESRIBED MEDIATIONS SAMPLE INFORMATION Specimen type: Urine ollected: Received: Reported: Ordered: 08/08/ :00:00 AM 08/10/ :56:00 PM 09/14/ :40:01 AM 08/08/ :00:00 AM SPEIMEN VALIDITY Test Outcome Measured Reference Range omment NORMAL to Specimen result within valid range. Specific Gravity NORMAL to Specimen result within valid range URINE REATININE NORMAL to 350 Specimen result within valid range Drug AMPHETAMINES BARBITUATES BENZODIAZEPINES BUPRENORPHRINE ANNABINOIDS OAINE ETHANOL FENTANYL METHADONE METHAMPHETAMINES OPIATES OXYODONE PHENYLIDINE TRAMADOL TRIYLI ANTIDEPRESSANT (TA) Type Result omments utoff Units Note: These tests were developed and their performance characteristics determined by AP Diagnostics and have not been cleared or approved by the FDA. The laboratory is regulated under LIA as qualified to perform high-complexity testing. These tests are used for clinical purposes only and should not be used for workplace drug testing, athletic doping control, or in any other forensic or legal context where chain of custody is required.
10 AP Diagnostics 935 Sundrop t Laboratory Report Phone: Fax: PATIENT INFORMATION Patient Name: MRN: Joseph Lister Patient DOB: 10/04/1965 Sample ID: Ordering Physician: REQUESTER INFORMATION Practice Name: Practice Address: AP Visions LL 395 Sundrop t SAMPLE INFORMATION Specimen type: Urine ollected: 08/09/ :00:00 AM Received: 08/10/ :55:00 PM Reported: 09/14/ :36:11 AM Ordered: 08/09/ :00:00 AM Fentanyl,Fioricet,Klonopin,Soma,Tramadol REPORTED LINIAL HISTORY - PRESRIBED MEDIATIONS Prescribed Medications(s) ONSISTENT - RESULTS ORRELATE WITH REPORTED LINIAL HISTORY Expected Drug and/or Metabolite Amount Detected ng/ml ut-off ng/ml Interpretation omments Fentanyl FENTANYL POSITIVE Test result is consistent and expected with reported medication Fentanyl. NORFENTANYL POSITIVE Tramadol TRAMADOL > POSITIVE Test result is consistent and expected with reported medication Tramadol. Prescribed Medication(s) INONSISTENT - RESULTS DO NOT ORRELATE WITH REPORTED LINIAL HISTORY Expected Drug and/or Metabolite Amount Detected ut-off Interpretation omments Klonopin LONAZEPAM NEGATIVE The test results are inconsistent with the expected positive result from the reported medication Klonopin. Soma ARISOPRODOL NEGATIVE The test results are inconsistent with the expected positive result from the reported medication Soma. Medication(s) or Drug(s) None MEPROBAMATE 2 NEGATIVE PRESENT - RESULTS DO NOT ORRELATE WITH REPORTED LINIAL HISTORY Expected Drug and/or Metabolite Amount Detected ut-off Interpretation None None None None omments Fioricet MEDIATIONS REPORTED BUT NOT TESTED SPEIMEN VALIDITY Test Outcome Measured Reference Range omment NORMAL to Specimen result within valid range. Specific Gravity NORMAL to Specimen result within valid range URINE REATININE ABNORMAL to 350 Urine specimens with creatinine levels between 10 and 20 ug/dl may be due to increased liquid consumption.
11 AP Diagnostics 935 Sundrop t Laboratory Report Phone: Fax: PATIENT INFORMATION Patient Name: Joseph Lister MRN: Patient DOB: 10/04/1965 Sample ID: Fentanyl, Fioricet, Klonopin, Soma, Tramadol Ordering Physician: REQUESTER INFORMATION Practice Name: Practice Address: AP Visions LL 395 Sundrop t REPORTED LINIAL HISTORY - PRESRIBED MEDIATIONS SAMPLE INFORMATION Specimen type: Urine ollected: Received: Reported: Ordered: 08/09/ :00:00 AM 08/10/ :55:00 PM 09/14/ :36:11 AM 08/09/ :00:00 AM Analgesic/Anesthetic FENTANYL NORFENTANYL TRAMADOL Benzodiazepines ALPHA-HYDROXYALPRAZOLAM ALPRAZOLAM LONAZEPAM LORAZEPAM NORDIAZEPAM OXAZEPAM TEMAZEPAM Drug AMPHETAMINES BARBITUATES BENZODIAZEPINES BUPRENORPHRINE ANNABINOIDS OAINE ETHANOL FENTANYL METHADONE METHAMPHETAMINES OPIATES OXYODONE PHENYLIDINE TRAMADOL TRIYLI ANTIDEPRESSANT (TA) Illicit Drugs 6-MAM BENZOYLEGONINE MDA MDMA PP Muscle Relaxants ARISOPRODOL MEPROBAMATE Opiates BUPRENORPHRINE ODEINE EDDP HYDROODONE HYDROMORPHONE MEPERIDINE METHADONE MORPHINE NALOXONE NALTREXONE NORBUPRENORPHINE NORMEPERIDINE OXYODONE OXYMORPHONE PROPOXYPHENE Stimulants AMPHETAMINE METHAMPHETAMINE Type Result > Positive Positive omments consistent consistent consistent inconsistent inconsistent inconsistent utoff Units
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
More informationDrug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
More information1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
More informationA Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography
Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical
More informationA Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS
A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement
More informationTest Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine
Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and
More informationSeptember HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
More informationLCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching
Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
More informationPhysician s Reference for Urine and Blood Drug Testing and Interpretation
Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine
More informationThe Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
More informationPowering Efficient Behavioral Health Care Services
Powering Efficient Behavioral Health Care Services Streamlining behavioral health care decisions through comprehensive and efficient drug monitoring Quest Diagnostics has you and your patients covered
More informationTest Definition: PCDSO Pain Clinic Drug Screen, Urine
Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle
More informationUsing Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
More informationUrine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationnextgen precision Test Report
nextgen precision TM Test Report SUMMARY OF PRECISION S NEXTGEN TEST REPORT In an effort to provide as much clinical insight as possible to our providers, we created our comprehensive NextGen Precision
More informationLabDriver Audit Trail Example
LabDriver Audit Trail Example Sample details:= (SampleDId=82051) Lab no: 0902168 Centre: CR Centre (CentreId=1079) (BatchSId=1317) Status: Checked Blood date: 13/05/2009 time: 11:31:00 lab received: 13/05/2009
More informationComparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs
Seyed Sadjadi, Shahana Huq, Sean Orlowicz and Laura Snow Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis
More informationSchedule of Accreditation
Schedule of Accreditation Organisation Name Trading As INAB Reg No Contact Name Address Medical Bureau Of Road Safety 30T Helen Kearns Contact Phone No 01-7165555 Email Website Accreditation Standard Health
More informationValidation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens
Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of
More informationAlcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082
Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending
More informationPain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
More informationRaPId ExamS multi-drug TEST CaRd TRaINING
RaPId ExamS muli-drug ES ard RaINING Features and Benefits 3 Accurate results in 5 minutes 3 Easy to read 3 Simple procedure 3 18-month shelf life 3 Available in single- and multiple-test panels 3 No urine
More informationPAIN PANEL. Research and Solutions
PAIN PANEL Research and Solutions Pain management drug use and abuse has increased significantly in recent years. The 21 National Survey on Drug Use & Health (NSDUH) reports that 17.3% of first-time drug
More informationNEW. Kinetex. Biphenyl TMS TMS TMS TMS. Selectivity that a C18 just can t give you!
Core-Shell Technology NEW Kinetex enyl Biph Biphenyl TM S TM Selectivity that a C8 just can t give you! S Bip he ylhenyl Bnip Remarkable Separation Power Rugged and Reliable % Aqueous Stable Kinetex Core-Shell
More informationLaboratory Service Report
4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric
More informationE XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS
FORENSICS UCT E XCEL LENCE JUST GOT BETTER CLEAN SCREEN XCEL SPE COLUMNS CLEAN SCREEN XCEL COLUMNS EXTRACTION OF BASIC DRUGS AND METABOLITES FROM URINE/ BLOOD USING SPE CARTRIDGES 130mg Clean Screen Xcel
More informationRapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab
Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie
More informationUrine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
More informationPain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
More informationLaboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
More informationORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS
ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer
More informationValidation of an Automated Method to Remove
Shahana Wahab Huq 1, Richard Thomas 2, Agnes Cua 2, Seyed Sadjadi 1 1 Phenomenex, 411 Madrid Avenue, Torrance, CA 951 2 Precision Toxicology, 33 Bunker Hill Street, San Diego, CA 9219 Validation of an
More informationUltra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.
Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.0 Software Xiang He 1, Adrian M. Taylor 2, Michael Jarvis 2 and Alexandre Wang
More informationFully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids
PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.
More informationPain Medication Management Program Supports Patient Outcomes and Adherence
PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety
More informationWelcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction
Welcome - SAMHSA s Role 2 Welcome and Opening Remarks The National Conference on Substance Abuse, Child Welfare and the Courts Division of Workplace Programs Ron R. Flegel, BSMT, M.S. and Charles Lodico,
More informationProof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Robert M. Sears, Toxicology Technical Leader 1, Kenneth
More informationINTERPATH LABORATORY, INC. TEST UPDATES
EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to
More informationPAIN PANEL. Application Guide. Screen 41 compounds in under 4 minutes
Application Guide PAIN PANEL Screen 41 compounds in under 4 minutes Solutions for large compound screens and individual compound classes such as benzodiazepines, opiates, and more Achieve resolution of
More information[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS
A Comprehensive Method for the Analysis of Pain Management Drugs and Drugs of Abuse Incorporating Simplified, Rapid Mixed-Mode SPE with UPLC-MS/MS for Clinical Research Jonathan P. Danaceau, Scott Freeto,
More informationToxicology Practice and Procedure Handbook
Toxicology Practice and Procedure Handbook Table of Contents Welcome Letter...3 Lab Requisition Protocol...4 Urine Collection and Shipment Protocol...5 Drug Confirmation Composite Profiles...8 Drug and
More informationWhat Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital
What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.
More informationSubstance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004
Substance Abuse Testing Electronic Result Reporting Layout Specifications Version 3.2 January 2004 Copyright Notice This publication is produced and distributed by LabOne, Inc. to specify the content and
More informationUrine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
More informationRapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System
Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System Xiang He, 1 Casey Burrows 1, Matthew Noestheden 2, Michael Jarvis, 2 Adrian Taylor,
More informationAgilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1
Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications dr. Jan Srbek, HPST Page 1 Major LC-MS Clinical Applications Steroids/Endocrinology Vitamin D Testosterone, Estradiol
More informationEvaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure
More informationLC Application Note. Dangerous driver?
LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham
More informationUrine Drug Screening: The Essentials of Interpretation
Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College
More informationComparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs. Table 1. List of pain panel drugs
APPLICATION Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs Seyed Sadjadi, Shahana Huq, Sean Orlowicz, and Laura Snow Phenomenex, 4 Madrid Avenue, Torrance,
More informationGet Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
More informationFrequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up
Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty
More information10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire
More informationWelcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017
Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug
More informationTesting for Controlled Substances
Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug
More informationVIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER
VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,
More informationEDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing
EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE
More informationMass Spectrometry in Precision Medicine --A Penn Experience in Metabolomics and TDM
Mass Spectrometry in Precision Medicine --A Penn Experience in Metabolomics and TDM Ping Wang, PhD, DABCC, FACB Chief of Clinical Chemistry Director of Core Laboratory Hospital of University of Pennsylvania
More informationToxicology Testing Is it a Good Fit for Your Laboratory? Rebecca Kenner, BA, MT, DLM(ASCP) Leigh Ann Smith, BS, MLS(ASCP), CLS
Thursday April 6, 2017 B16 Toxicology Testing Is it a Good Fit for Your Laboratory? Rebecca Kenner, BA, MT, DLM(ASCP) Leigh Ann Smith, BS, MLS(ASCP), CLS Global Analytical Development DESCRIPTION: Are
More informationMETHAMPHETAMINE & AMPHETAMINE
METHAMPHETAMINE & AMPHETAMINE Enantiomers from Urine Rapid and Accurate Chiral Separation Polysaccharide Chiral Chiral LC LC Columns and SFC PHEN-RUO-49 Revision: Lux 3 µm AMP Column High Efficiency LC/MS/MS
More informationPrescription Drug Monitoring Reference Guide: 2017
Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Test Codes Test Codes Drug/Drug Class P P,D,M P,D D,M D Alcohol Metabolites 90079 16910 92142 16217 Amphetamines 92222 70245
More informationCommunity Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4
Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Office of National Drug Control Policy Executive Office of the President May 2017 ACKNOWLEDGMENTS This report was funded by Cooperative
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationDRUGS OF ABUSE
DRUGS OF ABUSE www.btnx.com 1-888-339-9964 Rapid Response Drugs of Abuse and Alcohol Screening Devices BTNX Inc. prides itself in offering quality drug detection tests for accurate, safe and rapid testing.
More informationUrine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016
Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of
More informationCaring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM
Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, 2018 12 1 PM Audio is available through your computer speakers. Mission Maine Quality Counts is a nonprofit
More informationEvaluation of the Integrated E-Z Split Key Cup II for Rapid Detection of Twelve Drug Classes in Urine
Technical Note Evaluation of the Integrated E-Z Split Key Cup II for Rapid Detection of Twelve Drug Classes in Urine Dina N. Greene, Christopher M. Lehman, and Gwendolyn A. McMillin* University of Utah
More informationDrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.
DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide The information in this presentation is a general overview on using Confirm BioSciences DrugConfirm Advanced urine drug test cup; however,
More informationEuropean Guidelines for Workplace Drug Testing in UrineandOral fluid
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current
More informationEuropean Guidelines for Workplace Drug Testing in Blood and Blood Spots
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current
More informationDrugConfirm Advanced Urine Dip Cards.
DrugConfirm Advanced Urine Dip Cards The information in this presentation is a general overview on using the Confirm BioSciences DrugConfirm Advanced drug test cup but can be applied to many similarly
More informationDrug Early Warning Signals (DEWS): Operation PAR North Fort Myers, Florida
Drug Early Warning Signals (DEWS): Operation PAR North Fort Myers, Florida Office of National Drug Control Policy Executive Office of the President March 2019 ACKNOWLEDGMENTS This report was funded by
More informationPowerful Sample Prep and LC Column Solutions for Forensic Toxicology Applications
Thank you for joining us! Our session will begin shortly Powerful Sample Prep and LC Column Solutions for Forensic Toxicology Applications While you are waiting, please feel free to browse our library
More informationCommunity Drug Early Warning System (CDEWS-3): Maryland -- Site 4 of 4
Community Drug Early Warning System (CDEWS-3): Maryland -- Site 4 of 4 Office of National Drug Control Policy Executive Office of the President July 2017 ACKNOWLEDGMENTS This report was funded by Cooperative
More informationAnalysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
Article in press - uncorrected proof Clin Chem Lab Med 2009;47(8):971 976 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.220 2009/180 Analysis and interpretation of drug testing results
More informationENROLLMENT CONFIRMATION
Step 1: Please review the Facility/Contact information. If any of the information is incorrect, please make the appropriate changes below: Facility/Contact Phone: (850)474-3660 Fax: (850)474-3659 6431
More informationWorkforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
News from Quest Diagnostics Media: Kim Gorode, 973.520.2800 Investors: Shawn Bevec, 973.520.2900 Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics
More informationLyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
More informationINSTANT DRUG SCREENING
................................ INSTANT DRUG SCREENING Rapid tests for the detection of drugs and their metabolites in urine and saliva A CEuropean Background NHS Supply Chain Approved Reliable, quick
More informationSubstance Use and Misuse in the Military
Substance Use and Misuse in the Military Terry A. Adirim, M.D., M.P.H. Deputy Assistant Secretary of Defense for Health Services Policy and Oversight Health Affairs Department of Defense The Military Health
More informationInterpretation of Pain Management Testing Results Using Case Examples
Interpretation of Pain Management Testing Results Using Case Examples Philip M. Sobolesky, 1 * Breland E. Smith, 1 Amadeo J. Pesce, 2 and Robert L. Fitzgerald 1 Background: Because of the increasing volume
More informationChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)
ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect
More informationDrugs Found in Medical Examiner Cases
s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam
More informationAPPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns
APPLICATION Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns Sean Orlowicz Manager, PhenoLogix When not in the lab, Sean
More informationImmunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain
Pain Physician 2017; 20:SE1-SE9 ISSN 2150-1149 Review Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain Marion L. Snyder,
More informationApplications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.
Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory
More informationKeep It Clean. Solid Phase Extraction Solutions for Drugs of Abuse Analysis. Neutral Drugs of Abuse Basic Drugs of Abuse
Keep It Clean Solid Phase Extraction Solutions for Drugs of Abuse Analysis Neutral Drugs of Abuse Basic Drugs of Abuse Strata -X-Drug B: Basic Drugs of Abuse Working with basic drugs? Here are 3 reasons
More informationPOINT OF CARE TESTING
POINT OF CARE TESTING POINT OF CARE INSTANT TESTING Randox Testing Services offers a wide range of products to enable you to carry out on-site drug and alcohol testing for instant results. Our products
More informationDrug & Alcohol Testing in. Canada. Point of Care Testing
Drug & Alcohol Testing in Canada Point of Care Testing Introduction We are the leading Canadian innovator of diagnostic testing products and services Verify Diagnostics has assisted governments, corporations,
More informationTRIM reference DD17/ Endorsed by Publication date Review date
Participant procedure: drug Procedures provide practical step by step guidance to describe processes and actions required to enable the implementation of a policy or guideline. They can also be developed
More informationControlled Substance Monitoring in the Age of the Opioid Epidemic
Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,
More informationDrugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler
Drugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler Fred D. Foster 1, John R. Stuff 1, Jacqueline A. Whitecavage 1, Edward A. Pfannkoch 1, Mark
More informationQuest Diagnostics Drug Testing Index Full Year 2015 Tables
Quest Diagnostics Drug Testing Index Full Year 2015 Tables Table 1. Annual Positivity Rates Urine Drug Tests (For Combined U.S. Workforce) (More than 9.5 million tests from January to December 2015) Year
More informationTITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:
TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: 4.19.16 LAST REVISED DATE: 4.19.16 LAST REVIEWED DATE: 4.19.16 Table of Contents 1. How do I conduct my first few visits with a patient who
More informationOne of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing
& One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing Speaker Frederick G. Strathmann Learning Objectives Discuss
More informationMEDICAL POLICY Drug Testing
POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each
More information